{ }
001122334455554433221100
001122334455554433221100

UBS reduces Symrise price target to 121 euros while maintaining buy rating

UBS has reduced its target price for Symrise from 128 to 121 euros while maintaining a "buy" rating. Analyst Charles Eden anticipates that upcoming quarterly figures will reveal lower organic sales growth than previously expected, although he believes the company's annual targets remain achievable. The adjustment in the price target is primarily attributed to a decline in industry valuation.

ubs lowers symrise price target but maintains buy rating

UBS has reduced its price target for Symrise from 128 to 121 euros while maintaining a "Buy" rating. Analyst Charles Eden anticipates lower organic sales growth in the upcoming quarterly figures but believes the company's annual targets remain achievable despite the industry's lower valuation.

ubs maintains buy rating for symrise with price target of 133 euros

UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 133 euros, despite a 1.0% drop in share price to EUR 100.40. Analyst Charles Eden highlighted strong operating results and margin forecasts for 2025, although organic sales growth in Q4 fell short due to hyperinflation and exchange rate issues. The stock has seen a 2.2% decline since the start of 2025, with earnings figures for Q4 2024 expected on March 27, 2025.

Symrise shares rated buy by UBS with price target of 133 euros

UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 133 euros. Analyst Charles Eden praised the company's operating results for the second half of the year, despite organic sales growth in Q4 falling short due to hyperinflation and exchange rate issues. Currently, Symrise shares are trading at 100.45 euros, reflecting a 0.9% decline, with a potential upside of 32.4% relative to the target price.

UBS maintains buy rating for Symrise with price target of 133 euros

UBS has maintained a "Buy" rating for Symrise, setting a price target of 133 euros following the company's recent figures. Analyst Charles Eden expressed optimism about the operating results for the second half of the year and the margin forecast for 2025, despite organic sales growth in Q4 falling short due to hyperinflation and exchange rate issues.

ubs maintains buy rating for symrise with price target of 133 euros

UBS AG has maintained a "Buy" rating for Symrise, setting a price target of 133 euros, despite a 1.0% drop in share price to EUR 100.40. Analyst Charles Eden highlighted strong operating results and a positive margin forecast for 2025, although Q4 organic sales growth fell short due to hyperinflation and exchange rate issues. The share has a potential upside of 32.47% relative to the target price, with 230,036 shares traded so far.

ubs maintains buy rating for symrise with positive margin outlook

UBS has maintained a 'Buy' rating for Symrise, setting a price target of 133 euros. Analyst Charles Eden expressed optimism about the company's operating results for the second half of the year and the margin forecast for 2025, despite organic sales growth in Q4 falling short due to hyperinflation and exchange rate issues.

ubs lowers givaudan price target while maintaining neutral rating

UBS AG has reduced its price target for Givaudan shares from 4380 to 4310 Swiss francs while maintaining a "Neutral" rating. The adjustment reflects changes in estimates and a slight decline in industry valuation, with the stock currently trading at CHF 4,036.00, indicating a potential upside of 6.79%. Givaudan is set to release its Q2 2025 financial results on July 22, 2025.

ubs lowers givaudan price target while maintaining neutral rating

UBS has reduced its price target for Givaudan from 4380 to 4310 Swiss francs while maintaining a "Neutral" rating. This adjustment reflects changes in estimates and a slight decline in industry valuation. The company's 2024 financial figures align with expectations, and discussions among investors are focused on volume trends for 2025.

givaudan faces mixed analyst ratings as target prices fluctuate

Givaudan achieved a historic milestone in 2024, reporting net profits exceeding one billion Swiss francs for the first time, with a net profit of 1.09 billion francs and a revenue growth of 7.2% to 7.41 billion francs. Analysts have varied ratings, with Goldman Sachs maintaining a 'Buy' at 5100 francs, while Jefferies rates it 'Underperform' at 3400 francs. The company is set to release its financial figures for 2024 on January 24, 2025, amid mixed market reactions.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.